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Introduction {#sec005}
============

Approximately 20--50% of critically ill patients experience intensive care unit-acquired weakness (ICU-AW) \[[@pone.0223185.ref001]--[@pone.0223185.ref003]\]. ICU-AW includes a wide variety of disorders caused by polyneuropathy and myopathy after ICU admission, and it is associated with reductions in health-related quality of life and increased risks of death after hospital discharge \[[@pone.0223185.ref004]--[@pone.0223185.ref007]\]. ICU-AW is potentially aggravated by long periods of bed rest due to routinely managed sedation and immobility \[[@pone.0223185.ref008]\]. Currently, mobilization interventions delivered in the ICU setting are accepted as a therapeutic intervention that potentially prevents or attenuates functional impairment and ICU-AW \[[@pone.0223185.ref009]--[@pone.0223185.ref011]\]. However, the timing of the initiation of mobilization is still being debated.

Early mobilization has been proposed as a promising intervention to counteract ICU-AW because it attenuates critical illness-associated muscle weakness \[[@pone.0223185.ref012]\]. In 2013, Berry et al. reported that early exercise has the potential to decrease the length of the hospital stay and improve function in patients with acute respiratory failure \[[@pone.0223185.ref013]\]. In 2017, Ramos Dos et al. proposed that early mobilization appears to be important for preventing postoperative complications, improving functional capacity and reducing the length of hospital stay of patients who underwent cardiac surgery \[[@pone.0223185.ref014]\]. In the same year, a study by Nydahl reported that early mobilization and physical rehabilitation for critically ill patients appear to be safe and have a low risk of potential adverse events \[[@pone.0223185.ref015]\]. According to the 2018 study by Zhang et al., early mobilization in the ICU exerts a positive and safe effect on hospital outcomes for patients who require mechanical ventilation (MV) because it confers the significant benefit of decreasing the duration of MV and the length of stay in the ICU \[[@pone.0223185.ref016]\].

However, numerous opposing opinions have been reported in many published papers. In 2015, a meta-analysis conducted by Castro-Avila et al. argued that early rehabilitation during the ICU stay is not associated with improvements in the functional status, muscle strength, quality of life or health care utilization outcomes \[[@pone.0223185.ref017]\]. In 2016, a qualitative review suggested that early exercise in the ICU is feasible and safe, but the potential benefit of earlier program initiation has not been clearly shown \[[@pone.0223185.ref018]\]. In 2018, Doiron et al. reported mixed results for the effect of early movement or exercise on physical function, and described the difficulty in determining whether early movement or exercise performed by critically ill people in the ICU improves their abilities to perform daily activities, muscle strength, or quality of life \[[@pone.0223185.ref019]\].

In addition to the data presented above, the most recent Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption (PADIS) guideline (2018) suggests that rehabilitation or mobilization can be safely initiated in critically ill adults when the cardiovascular, respiratory, and neurological statuses are stable \[[@pone.0223185.ref020]\]. Moreover, many recent studies focusing on the effect of early rehabilitation within the ICU have been published. Thus, the effect of early mobilization on critically ill patients in the ICU should be re-examined. Based on these, we conducted this study aim to comprehensively assess the evidence available regarding the effect of early mobilization on critically ill patients in the ICU.

Materials and methods {#sec006}
=====================

This meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines ([S1 Text](#pone.0223185.s001){ref-type="supplementary-material"}) \[[@pone.0223185.ref021]\]. Ethical approval was not required for this study.

Search strategy {#sec007}
---------------

PubMed, EMBASE, Web of Science, and the Cochrane Library were independently searched from their inception to March 21, 2019 by two investigators using the keywords \"early ambulation\", \"mobilization\", \"rehabilitation\", \"physical therapy\", \"intensive care unit\", and \"randomized controlled trial\", as well as their respective synonyms and derivations ([S2 Text](#pone.0223185.s002){ref-type="supplementary-material"}). The publication language was restricted to English. Relevant articles were also identified by reviewing the reference lists of the retrieved papers and conference literature.

Study selection {#sec008}
---------------

Two investigators independently reviewed all the studies. Disagreements were resolved through a discussion with a third investigator.

The following inclusion criteria were used for the primary studies: (1) Population: adult patients (≥18 years old or according to local law), (2) Design: randomized controlled trial (RCT), and (3) Intervention: patients in the intervention group received early mobilization. The eligibility criteria for \"early mobilization\" was based on previously published meta-analyses and the new PADIS guideline \[[@pone.0223185.ref020],[@pone.0223185.ref022],[@pone.0223185.ref023]\]. Early mobilization was initiated when (1) the cardiovascular, respiratory, and neurological statuses of patients were stable and (2) patients in the intervention group began mobilization interventions earlier than the control group. Mobilization was defined as follows: (1) range of motion; (2) motion involving axial loading exercises, movements against gravity, active activities, and activities requiring energy expenditure of patients; (3) 'active' was indicated in the early mobilization definitions as patients with muscle strength and an ability to control the activities, a conscious muscle activation (except breathing) and certain types of activities, such as activities with physiological benefits, strengthening and mobility exercises and assisted exercises. Patients in the control group received the standard or usual treatment. (4) Outcomes included muscle strength (such as the Medical Research Council (MRC) sum score, ICU-AW, handgrip force, and quadriceps force), functional mobility capacity (ablility to stand, unassisted walking distance, time to walk, and so on), duration of MV, ventilator-free days, mortality rates (28-day, ICU, and hospital), discharged-to-home rate, and adverse events.

The exclusion criteria for the primary studies were (1) patients with neurological conditions (e.g., brain injury, stroke, or spinal cord injury); (2) the inclusion of ineligible interventions, such as, neuromuscular electric muscle stimulation, continuous lateral rotation of the bed, lateral positioning in bed, inspiratory muscle training/diaphragmatic electrical stimulation/breathing exercises, chest physiotherapy/airway clearance, massage therapy, and stroke rehabilitation; (3) exercises performed after ICU discharge; (4) reviews, abstracts, and case reports; (5) pediatric, animal or cell-based studies; and (6) duplicate publications.

Quality and risk of bias assessments {#sec009}
------------------------------------

The methodological quality and risk of bias of each eligible trial were independently assessed using the Cochrane Collaboration tool for assessing risk of bias in randomized trials by two investigators \[[@pone.0223185.ref024]\]. Any discrepancies were resolved through discussion with a third investigator.

Data extraction {#sec010}
---------------

A standard collection form was used to extract related data from the included trials. The extracted data comprised the first author, year of publication, sample size, demographics, and clinical outcomes. The author was contacted by email if additional information associated with a study was needed; if a response was not obtained, the study was excluded.

Data processing and statistical analyses {#sec011}
----------------------------------------

The STATA v12.0 statistical software was used in the meta-analysis. For dichotomous variables (e.g., mortality rate, discharged-to-home rate, and adverse events), the relative risk (RR) and 95% confidence interval (CI) were calculated using the Mantel-Haenszel (M-H) test. For continuous variables (e.g., duration of MV, ventilator-free days, unassisted walking distance, and so on), the weighted mean difference (WMD) or standardized mean difference (SMD) and 95% CI were calculated using the inverse-variance (I-V) test.

Heterogeneity was estimated using *I*^*2*^ statistics \[[@pone.0223185.ref025]\]. If significant heterogeneity (*I*^*2*^≥50%) was present, the random-effects model was used. Otherwise, the fixed-effects model was used. Both sensitivity and subgroup analyses were employed to investigate possible sources of high heterogeneity (*I*^*2*^≥50%).

A funnel plot was constructed to evaluate publication bias only if a sufficient number of studies (≥10) was present. The significance of the pooled index was determined using the Z test. A two-sided *P*-value ≤0.05 was considered statistically significant.

Results {#sec012}
=======

Search results {#sec013}
--------------

As shown in [Fig 1](#pone.0223185.g001){ref-type="fig"}, 1,898 studies were retrieved after the initial search. After duplicates were removed, 1,058 records remained. After reading the text, 23 studies (N = 2,308 patients) were eligible for inclusion and analysis in this meta-analysis \[[@pone.0223185.ref026]--[@pone.0223185.ref048]\].

![Flow diagram of the study selection process.](pone.0223185.g001){#pone.0223185.g001}

Demographic characteristics of the population {#sec014}
---------------------------------------------

The demographic characteristics of the patients in the included studies are summarized in [Table 1](#pone.0223185.t001){ref-type="table"}. The enrolled patients consisted of 1,352 males and 956 females. The mean age of the included patients ranged from 44.9 to 65.5 years. Eighteen studies reported Acute Physiology and Chronic Health Evaluation (APACHE) II scores; the mean APACHE II scores ranged from 15.5 to 27.5 points \[[@pone.0223185.ref026],[@pone.0223185.ref028],[@pone.0223185.ref029],[@pone.0223185.ref031],[@pone.0223185.ref033]--[@pone.0223185.ref035],[@pone.0223185.ref037]--[@pone.0223185.ref047]\]. One study reported a Simplified Acute Physiology Score II \[[@pone.0223185.ref030]\]. One study reported an APACHE III score \[[@pone.0223185.ref036]\]. All included studies were performed in different countries, such as Canada, France, United Kingdom, and China.

10.1371/journal.pone.0223185.t001

###### Demographics of patients in the included studies.
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  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Year   Authors                                         Size\   Gender\   Age\            APACHE II                                           Region
                                                         (n)     (M/F)     (years)                                                             
  ------ ----------------------------------------------- ------- --------- --------------- --------------------------------------------------- ------------------------
  2019   Kho et al. \[[@pone.0223185.ref026]\]           66      40/26     61.6±16.9       23.5±8.6                                            Canada

  2018   Sarfati et al. \[[@pone.0223185.ref027]\]       145     98/47     64.0±3.5        Not reported                                        France

  2018   McWilliams et al. \[[@pone.0223185.ref028]\]    102     62/40     61.5±5.6        17.5±1.8                                            United Kingdom

  2018   Hickmann et al. \[[@pone.0223185.ref029]\]      19      11/8      58.5±19.5       18.5±6.6                                            Belgium

  2018   Fossat et al. \[[@pone.0223185.ref030]\]        312     204/108   65.5±14.1       46.5±18.1[\*](#t001fn001){ref-type="table-fn"}      France

  2018   Eggmann et al. \[[@pone.0223185.ref031]\]       115     67/48     64.5±15.0       22.5±7.6                                            Switzerland

  2017   Maffei et al. \[[@pone.0223185.ref032]\]        40      31/9      53.5±9.0        Not reported                                        United Kingdom

  2017   Machado et al. \[[@pone.0223185.ref033]\]       38      23/15     44.9±19.2       17.7±6.6                                            Brazil

  2016   Schaller et al. \[[@pone.0223185.ref034]\]      200     126/74    65.0±4.6        20.0±4.3                                            Austria, Germany, USA

  2016   Moss et al. \[[@pone.0223185.ref035]\]          120     71/49     52.5±14.5       17.6±5.9                                            USA

  2016   Morris et al. \[[@pone.0223185.ref036]\]        300     134/166   56.0±15.0       76.0±27.0 [^\#^](#t001fn002){ref-type="table-fn"}   USA

  2016   Hodgson et al. \[[@pone.0223185.ref037]\]       50      30/20     58.5±13.3       17.9±8.8                                            Australia, New Zealand

  2016   Dong et al. \[[@pone.0223185.ref038]\]          106     42/64     61.4±14.2       16.8±4.3                                            China

  2016   Coutinho et al. \[[@pone.0223185.ref039]\]      25      12/13     58.5±22.9       25.7±6.7                                            Brazil

  2015   Kayambu et al. \[[@pone.0223185.ref040]\]       50      32/18     64.0±12.67      27.5±7.23                                           Australia

  2014   Dong et al. \[[@pone.0223185.ref041]\]          60      41/19     55.4±16.2       15.5±4.2                                            China

  2014   Brummel et al. \[[@pone.0223185.ref042]\]       87      49/38     61.0±4.7        25.1±2.8                                            USA

  2013   Denehy et al. \[[@pone.0223185.ref043]\]        160     95/65     60.8**±**15.9   19.9±7.0                                            Australia

  2012   Dantas et al. \[[@pone.0223185.ref044]\]        28      11/17     54.8±18.4       22.4±7.9                                            Brazil

  2011   Chang et al. \[[@pone.0223185.ref045]\]         34      21/13     66.1±13.8       16.0±8.0                                            Taiwan

  2009   Schweickert et al. \[[@pone.0223185.ref046]\]   104     52/52     56.1±6.8        19.5±2.3                                            USA

  2009   Burtin et al. \[[@pone.0223185.ref047]\]        67      49/19     56.5±16.3       25.5±5.5                                            Belgium

  1998   Nava et al. \[[@pone.0223185.ref048]\]          80      51/29     66.0±7.7        Not reported                                        Italy
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* Simplified Acute Physiology Score II

^\#^APACHE Ⅲ score

APACHE II: Acute Physiology and Chronic Health Evaluation II; USA: United States of America.

As shown in [S1 Table](#pone.0223185.s003){ref-type="supplementary-material"}, the causes of the ICU stay included MV \[[@pone.0223185.ref026]--[@pone.0223185.ref031],[@pone.0223185.ref033]--[@pone.0223185.ref041],[@pone.0223185.ref043]--[@pone.0223185.ref046]\], liver transplant \[[@pone.0223185.ref028]\], respiratory failure and/or shock \[[@pone.0223185.ref042]\], prolonged ICU stay \[[@pone.0223185.ref047]\] and chronic obstructive pulmonary disease with respiratory failure \[[@pone.0223185.ref048]\]. Two studies were performed in a respiratory ICU \[[@pone.0223185.ref035],[@pone.0223185.ref048]\], six studies were performed in a surgical ICU \[[@pone.0223185.ref027],[@pone.0223185.ref034],[@pone.0223185.ref042],[@pone.0223185.ref045]--[@pone.0223185.ref047]\], and the remaining studies were performed in a general ICU. Seven studies were multicenter RCTs \[[@pone.0223185.ref026],[@pone.0223185.ref034],[@pone.0223185.ref035],[@pone.0223185.ref037],[@pone.0223185.ref042],[@pone.0223185.ref046],[@pone.0223185.ref047]\].

Treatment protocols {#sec015}
-------------------

The treatment protocols used in the included studies are summarized in [S2 Table](#pone.0223185.s004){ref-type="supplementary-material"}. Thirteen studies reported a clear definition of 'early', such as "within five days of admission to critical care or ICU" \[[@pone.0223185.ref026],[@pone.0223185.ref028],[@pone.0223185.ref029],[@pone.0223185.ref033],[@pone.0223185.ref043],[@pone.0223185.ref048]\], "within one day after trial enrollment" \[[@pone.0223185.ref034],[@pone.0223185.ref035],[@pone.0223185.ref037]\], "after coronary artery bypass grafting in the ICU" \[[@pone.0223185.ref038]\], "within 48 hours of the diagnosis of sepsis" \[[@pone.0223185.ref040]\], "during the sedated and intubated phase of their postoperative course" \[[@pone.0223185.ref032]\], and "at least 24 hours and not more than 48 hours of invasive MV" \[[@pone.0223185.ref039]\]. The remaining studies did not provide a clear definition of early mobilization but included the term \"early\" when describing the intervention group \[[@pone.0223185.ref027],[@pone.0223185.ref030],[@pone.0223185.ref031],[@pone.0223185.ref036],[@pone.0223185.ref041],[@pone.0223185.ref042],[@pone.0223185.ref044]--[@pone.0223185.ref047]\]. The participants in the intervention group received in-bed cycling on a cycle ergometer \[[@pone.0223185.ref026],[@pone.0223185.ref029]--[@pone.0223185.ref031],[@pone.0223185.ref033],[@pone.0223185.ref039],[@pone.0223185.ref047]\], mobilization or rehabilitation \[[@pone.0223185.ref027],[@pone.0223185.ref034],[@pone.0223185.ref036]--[@pone.0223185.ref038],[@pone.0223185.ref040],[@pone.0223185.ref041],[@pone.0223185.ref043],[@pone.0223185.ref044],[@pone.0223185.ref046],[@pone.0223185.ref048]\], enhanced or intensive rehabilitation \[[@pone.0223185.ref028],[@pone.0223185.ref032],[@pone.0223185.ref035]\], or a physiotherapy intervention \[[@pone.0223185.ref042],[@pone.0223185.ref045]\]. Compared with the intervention groups, participants in the control groups received later or standardized mobilization interventions in the included studies.

Quality and risk of bias {#sec016}
------------------------

The methodological quality and risk of bias of each eligible study were evaluated using the Cochrane Collaboration tool for assessing the risk of bias, and the results are presented in [Table 2](#pone.0223185.t002){ref-type="table"}. All studies were randomized. Seventeen studies reported the method of random sequence generation, such as computer generation \[[@pone.0223185.ref026]--[@pone.0223185.ref028],[@pone.0223185.ref030],[@pone.0223185.ref031],[@pone.0223185.ref033],[@pone.0223185.ref036],[@pone.0223185.ref038],[@pone.0223185.ref040],[@pone.0223185.ref042],[@pone.0223185.ref045],[@pone.0223185.ref046],[@pone.0223185.ref048]\] internet-based access to a restricted platform \[[@pone.0223185.ref034]\], website randomization \[[@pone.0223185.ref039]\], and a random number table \[[@pone.0223185.ref043],[@pone.0223185.ref047]\]. Nine studies reported allocation concealment with envelopes \[[@pone.0223185.ref027],[@pone.0223185.ref030],[@pone.0223185.ref031],[@pone.0223185.ref037],[@pone.0223185.ref040],[@pone.0223185.ref042],[@pone.0223185.ref043],[@pone.0223185.ref045],[@pone.0223185.ref047]\], and three studies reported blinded allocation \[[@pone.0223185.ref028],[@pone.0223185.ref033],[@pone.0223185.ref046]\]. Two studies reported the blinding of participants and personnel \[[@pone.0223185.ref027],[@pone.0223185.ref040]\], and 12 studies reported blinding of the outcome assessments \[[@pone.0223185.ref026],[@pone.0223185.ref031],[@pone.0223185.ref033]--[@pone.0223185.ref037],[@pone.0223185.ref040],[@pone.0223185.ref042],[@pone.0223185.ref043],[@pone.0223185.ref046]\].

10.1371/journal.pone.0223185.t002

###### Quality and bias of the included trials.

![](pone.0223185.t002){#pone.0223185.t002g}

  Year   Authors                                         Selection bias   Performance and detection bias   Incomplete outcome data addressed   Selective reporting   Other bias              
  ------ ----------------------------------------------- ---------------- -------------------------------- ----------------------------------- --------------------- ------------ ---------- ----------
  2019   Kho et al. \[[@pone.0223185.ref026]\]           Low risk         Unclear                          High risk                           Low risk              Low risk     Low risk   Low risk
  2018   Sarfati et al. \[[@pone.0223185.ref027]\]       Low risk         Low risk                         Low risk                            High risk             Low risk     Low risk   Low risk
  2018   McWilliams et al. \[[@pone.0223185.ref028]\]    Low risk         Low risk                         High risk                           High risk             Low risk     Low risk   Low risk
  2018   Hickmann et al. \[[@pone.0223185.ref029]\]      Unclear          Unclear                          High risk                           High risk             Low risk     Low risk   Low risk
  2018   Fossat et al. \[[@pone.0223185.ref030]\]        Low risk         Low risk                         High risk                           High risk             Low risk     Low risk   Low risk
  2018   Eggmann et al. \[[@pone.0223185.ref031]\]       Low risk         Low risk                         High risk                           Low risk              Low risk     Low risk   Low risk
  2017   Maffei et al. \[[@pone.0223185.ref032]\]        Unclear          Unclear                          High risk                           High risk             Low risk     Low risk   Low risk
  2017   Machado et al. \[[@pone.0223185.ref033]\]       Low risk         Low risk                         High risk                           Low risk              Low risk     Low risk   Low risk
  2016   Schaller et al. \[[@pone.0223185.ref034]\]      Low risk         Unclear                          Low risk                            Low risk              Low risk     Low risk   Low risk
  2016   Moss et al. \[[@pone.0223185.ref035]\]          Unclear          Unclear                          Low risk                            Low risk              Low risk     Low risk   Low risk
  2016   Morris et al. \[[@pone.0223185.ref036]\]        Low risk         Unclear                          Low risk                            Low risk              Low risk     Low risk   Low risk
  2016   Hodgson et al. \[[@pone.0223185.ref037]\]       Unclear          Low risk                         High risk                           Low risk              Low risk     Low risk   Low risk
  2016   Dong et al. \[[@pone.0223185.ref038]\]          Low risk         Unclear                          High risk                           Low risk              Low risk     Low risk   Low risk
  2016   Coutinho et al. \[[@pone.0223185.ref039]\]      Low risk         Unclear                          High risk                           Low risk              Low risk     Low risk   Low risk
  2015   Kayambu et al. \[[@pone.0223185.ref040]\]       Low risk         Low risk                         Low risk                            Low risk              Low risk     Low risk   Low risk
  2014   Dong et al. \[[@pone.0223185.ref041]\]          Unclear          Unclear                          High risk                           Low risk              Low risk     Low risk   Low risk
  2014   Brummel et al. \[[@pone.0223185.ref042]\]       Low risk         Low risk                         High risk                           Low risk              Low risk     Low risk   Low risk
  2013   Denehy et al. \[[@pone.0223185.ref043]\]        Low risk         Low risk                         Low risk                            Low risk              Low risk     Low risk   Low risk
  2012   Dantas et al. \[[@pone.0223185.ref044]\]        Unclear          Unclear                          High risk                           High risk             Low risk     Low risk   Low risk
  2011   Chang et al. \[[@pone.0223185.ref045]\]         Low risk         Low risk                         High risk                           High risk             Low risk     Low risk   Low risk
  2009   Schweickert et al. \[[@pone.0223185.ref046]\]   Low risk         Low risk                         Low risk                            Blinded               Low risk     Low risk   Low risk
  2009   Burtin et al. \[[@pone.0223185.ref047]\]        Low risk         Low risk                         High risk                           Low risk              Low risk     Low risk   Low risk
  1998   Nava et al. \[[@pone.0223185.ref048]\]          Low risk         Unclear                          High risk                           High risk             Low risk     Low risk   Low risk

Muscle strength {#sec017}
---------------

Eight studies involving 763 patients reported changes in the Medical Research Council (MRC) sum score at ICU discharge \[[@pone.0223185.ref026]--[@pone.0223185.ref028],[@pone.0223185.ref030],[@pone.0223185.ref031],[@pone.0223185.ref033],[@pone.0223185.ref040],[@pone.0223185.ref044]\]. A pooled analysis of the data indicated that early mobilization did not increase the MRC sum score at ICU discharge (WMD: 0.95, 95% CI \[-1.72, 3.61\]; *p* = 0.487, *I*^*2*^ = 90.2%) ([S3 Table](#pone.0223185.s005){ref-type="supplementary-material"}). According to the sensitivity analyses, four studies were responsible for the high heterogeneity (*I*^*2*^ = 90.2%), due to the inclusion of patients who received short-term MV (≤4 days) \[[@pone.0223185.ref026]\], were treated in a surgical ICU \[[@pone.0223185.ref027]\], received electrical stimulation \[[@pone.0223185.ref030]\], and a lack of reporting of the method used for random sequence generation \[[@pone.0223185.ref044]\] ([S1 Fig](#pone.0223185.s012){ref-type="supplementary-material"}). After removing the four studies, pooled analysis of the data indicated the same result (WMD: 0.18, 95% CI \[-1.13, 1.49\]; *p* = 0.788, *I*^*2*^ = 0.0%) \[[@pone.0223185.ref028], [@pone.0223185.ref031],[@pone.0223185.ref033],[@pone.0223185.ref040]\] ([S3 Table](#pone.0223185.s005){ref-type="supplementary-material"}).

Five studies examining 414 patients reported changes in the MRC sum score at hospital discharge \[[@pone.0223185.ref026]--[@pone.0223185.ref028],[@pone.0223185.ref037],[@pone.0223185.ref046]\]. A pooled analysis of the data indicated that early mobilization did not increase the MRC sum score at hospital discharge (WMD: 0.76, 95% CI \[-0.18, 1.70\]; *p* = 0.114, *I*^*2*^ = 54.2%) ([S4 Table](#pone.0223185.s006){ref-type="supplementary-material"}). Based on the sensitivity analyses, one study (performed in a surgical ICU) performed by Sarfati et al. was responsible for the high heterogeneity (*I*^*2*^ = 54.2%), and was removed \[[@pone.0223185.ref027]\] ([S2 Fig](#pone.0223185.s013){ref-type="supplementary-material"}). A pooled analysis of the data from the remaining four studies indicated that early mobilization did not increase the MRC sum score at hospital discharge (WMD: 0.20, 95% CI \[-0.53, 0.92\]; *p* = 0.594, *I*^*2*^ = 45.2%) \[[@pone.0223185.ref026],[@pone.0223185.ref028],[@pone.0223185.ref037],[@pone.0223185.ref046]\] ([S4 Table](#pone.0223185.s006){ref-type="supplementary-material"}).

Five studies analyzing 419 patients reported the incidence of ICU-AW (MRC sum score \<48) \[[@pone.0223185.ref026],[@pone.0223185.ref027],[@pone.0223185.ref034],[@pone.0223185.ref037],[@pone.0223185.ref046]\]. The pooled analysis of the data indicated a decrease in the incidence of ICU-AW at hospital discharge following early mobilization (RR: 0.60, 95% CI \[0.40, 0.90\]; *p* = 0.013, *I*^*2*^ = 0.0%) ([Fig 2](#pone.0223185.g002){ref-type="fig"}), but not at ICU discharge (RR: 0.99, 95% CI \[0.80, 1.23\]; *p* = 0.936, *I*^*2*^ = 36.6%) ([S3 Fig](#pone.0223185.s014){ref-type="supplementary-material"}).

![Forest plot of the eligible studies that reported ICU-AW at hospital discharge.](pone.0223185.g002){#pone.0223185.g002}

Four studies reported handgrip force \[[@pone.0223185.ref031],[@pone.0223185.ref036],[@pone.0223185.ref046],[@pone.0223185.ref047]\], and three studies reported quadriceps force \[[@pone.0223185.ref031],[@pone.0223185.ref036],[@pone.0223185.ref047]\]. As shown in [S5 Table](#pone.0223185.s007){ref-type="supplementary-material"}, a difference was not observed between the early mobilization and control groups.

Functional mobility capacity {#sec018}
----------------------------

Sixteen studies including 1,758 patients examined the changes in functional mobility capacity using different mobility assessments at different time points \[[@pone.0223185.ref026]--[@pone.0223185.ref028],[@pone.0223185.ref030]--[@pone.0223185.ref032],[@pone.0223185.ref034],[@pone.0223185.ref035],[@pone.0223185.ref037],[@pone.0223185.ref040]--[@pone.0223185.ref043],[@pone.0223185.ref046]--[@pone.0223185.ref048]\]. In one study, early goal-directed mobilization increased the number of patients who were able to stand during hospitalization (90% vs. 62%, *p* = 0.02) \[[@pone.0223185.ref037]\]. According to another study, patients in the early physical and occupational therapy group recorded a greater unassisted walking distance (33.4 (0--91.4) meters vs. 0 (0--30.4) meters, *p* = 0.004) at hospital discharge \[[@pone.0223185.ref046]\]. In addition to these indicators, a comprehensive analysis showed that early mobilization failed to improve functional indicators ([S6](#pone.0223185.s008){ref-type="supplementary-material"} and [S7](#pone.0223185.s009){ref-type="supplementary-material"} Tables). However, due to the high heterogeneity, these results should be interpreted with caution.

Mechanical ventilation and ventilator-free days {#sec019}
-----------------------------------------------

Seventeen studies including 1,501 patients reported the duration of MV \[[@pone.0223185.ref026]--[@pone.0223185.ref033],[@pone.0223185.ref035],[@pone.0223185.ref037]--[@pone.0223185.ref041],[@pone.0223185.ref043],[@pone.0223185.ref045],[@pone.0223185.ref046]\]. The pooled analysis of the data indicated that early mobilization did not decrease the duration of MV (SMD: -0.33, 95% CI \[-0.66, -0.00\]; *p* = 0.051, *I*^*2*^ = 89.1%). As shown in [S8 Table](#pone.0223185.s010){ref-type="supplementary-material"}, analyses of different subgroups also failed to detect an effect of early mobilization on the duration of MV.

Six studies including 745 patients reported ventilator-free days \[[@pone.0223185.ref034],[@pone.0223185.ref036],[@pone.0223185.ref037],[@pone.0223185.ref040],[@pone.0223185.ref042],[@pone.0223185.ref046]\]. The pooled analysis of the data indicated that early mobilization increased the number of ventilator-free days (SMD: 0.17, 95% CI \[0.02, 0.31\]; *p* = 0.023, *I*^*2*^ = 35.5%) ([Fig 3](#pone.0223185.g003){ref-type="fig"}).

![Forest plot of the eligible studies that reported the number of ventilator-free days.](pone.0223185.g003){#pone.0223185.g003}

Mortality rate {#sec020}
--------------

Eighteen studies including 1,781 patients reported changes in the mortality rate at different time points. As shown in results of the pooled analysis of the data presented in [S9 Table](#pone.0223185.s011){ref-type="supplementary-material"}, early mobilization did not decrease the 28-day mortality rate (RR: 1.23, 95% CI \[0.81, 1.85\]; *p* = 0.330) \[[@pone.0223185.ref029],[@pone.0223185.ref030],[@pone.0223185.ref043]\], ICU mortality rate (RR: 1.12, 95% CI \[0.82, 1.52\]; *p* = 0.474) \[[@pone.0223185.ref026]--[@pone.0223185.ref028],[@pone.0223185.ref030],[@pone.0223185.ref031],[@pone.0223185.ref035],[@pone.0223185.ref037],[@pone.0223185.ref040]\], or hospital mortality rate (RR: 1.10, 95% CI \[0.89, 1.37\]; *p* = 0.380) \[[@pone.0223185.ref034],[@pone.0223185.ref037],[@pone.0223185.ref038],[@pone.0223185.ref041],[@pone.0223185.ref042],[@pone.0223185.ref046]--[@pone.0223185.ref048]\].

Discharged-to-home rate {#sec021}
-----------------------

Seven studies analyzing 793 patients reported the discharged-to-home rate \[[@pone.0223185.ref026],[@pone.0223185.ref034],[@pone.0223185.ref035],[@pone.0223185.ref037],[@pone.0223185.ref043],[@pone.0223185.ref046],[@pone.0223185.ref047]\]. As shown in [Fig 4](#pone.0223185.g004){ref-type="fig"}, moderate heterogeneity existed among these studies (χ^2^ = 9.76, *p* = 0.135, *I*^*2*^ = 38.5%), and a random fixed-effects M-H model was used. Early mobilization increased the discharged-to-home rate (RR: 1.16, 95% CI \[1.00, 1.34\]; *p* = 0.046).

![Forest plot of the eligible studies that reported the discharged-to-home rate.](pone.0223185.g004){#pone.0223185.g004}

Adverse events {#sec022}
--------------

Eight studies including 1,009 patients reported adverse events \[[@pone.0223185.ref026],[@pone.0223185.ref031],[@pone.0223185.ref034]--[@pone.0223185.ref036],[@pone.0223185.ref041],[@pone.0223185.ref042],[@pone.0223185.ref046]\]. As shown in [S4 Fig](#pone.0223185.s015){ref-type="supplementary-material"}, moderate heterogeneity was observed among these studies (χ^2^ = 10.04, *p* = 0.186, *I*^*2*^ = 30.3%), and a fixed-effects M-H model was used. Early mobilization did not increase the rate of adverse events (RR: 1.35, 95% CI \[0.86, 2.12\]; *p* = 0.195).

Publication bias {#sec023}
----------------

The funnel plot for the duration of MV (17 studies) is shown in [Fig 5](#pone.0223185.g005){ref-type="fig"}, and it shows no publication bias (Z = 0.30 (continuity corrected), Pr \> \|z\| = 0.767 \>0.05).

![Funnel plot of the 17 eligible studies that reported the duration of MV.](pone.0223185.g005){#pone.0223185.g005}

Discussion {#sec024}
==========

Twenty-three RCTs (2,308 patients) were included in this systematic review and meta-analysis. Publication bias was not identified. Based on the pooled results of this study, we concluded that regardless of the different techniques and periods of mobilization used, early mobilization of critically ill patients increased the number of people who were able to stand (90% vs. 62%, *p* = 0.02) and the number of ventilator-free days during hospitalization, decreased the incidence of ICU-AW, increased the walking distance at hospital discharge, and increased the discharged-to-home rate. The mortality (28-day, ICU and hospital) and adverse event rates were moderately increased by early mobilization, but the differences were not statistically significant.

Critically ill patients commonly develop severe muscle weakness due to hypercatabolism, deep sedation and immobility \[[@pone.0223185.ref049]\]. Muscle weakness impairs the functional capacity, leads to delayed recovery, impedes weaning from MV, increases financial costs, and decreases the quality of life of survivors \[[@pone.0223185.ref050]--[@pone.0223185.ref052]\]. Many clinical scales and dynamometry methods have been developed by researchers to reliably measure muscle force in the ICU.

A bedside evaluation of muscle strength using the MRC sum score (\<48) has been applied to diagnose ICU-AW in many current recommendations \[[@pone.0223185.ref053]\]. According to the present meta-analysis, early mobilization did not increase the MRC sum score at ICU and hospital discharge. However, early mobilization decreased the incidence of ICU-AW after hospital discharge. These results are consistent with two recent systematic reviews reporting that early physical therapy increases peripheral muscle strength \[[@pone.0223185.ref009], [@pone.0223185.ref010]\].

Handgrip strength, which can be measured using hand-held dynamometers, serves as an indicator of overall muscular strength \[[@pone.0223185.ref054]\]. Many studies have reported a lower handgrip strength in subjects with ICU-AW and an independently association with poor hospital outcomes \[[@pone.0223185.ref055]--[@pone.0223185.ref057]\]. Recent systematic reviews have shown that exercise training improves the skeletal muscle strength of patients with acute respiratory failure \[[@pone.0223185.ref013], [@pone.0223185.ref058]\]. However, in this systematic review, no differences in peripheral muscle strength measured using handgrip force and quadriceps force were observed between groups. A similar result was reported by Castro-Avila et al. \[[@pone.0223185.ref017]\].

Muscle strength maintenance is significantly correlated with an improvement in functional capacity \[[@pone.0223185.ref059]--[@pone.0223185.ref061]\]. Immobility is an important risk factor for functional impairment \[[@pone.0223185.ref004]\]. Many systematic reviews have reported that early mobilization is feasible, safe and well tolerated and promotes better functional outcomes in patients in the ICU \[[@pone.0223185.ref010],[@pone.0223185.ref062],[@pone.0223185.ref014],[@pone.0223185.ref063]\]. Therefore, the mainstream view is that critically ill patients should receive mobilization therapy as soon as possible.

In this meta-analysis, early mobilization increased the number of people who were able to stand during hospitalization and the walking distance at hospital discharge. These results support the previous hypothesis that early mobilization is beneficial for improving patients' functional mobility capacity.

However, early mobilization did not affect other functional scores (e.g., physical function score on the ICU test, functional status score on the ICU test, and Berg Balance Scale scores) at ICU/hospital discharge. This result differs from a previous systematic review showing that the Functional Independence Measure (FIM) score improved in the intervention group and after rehabilitation in the post-acute setting \[[@pone.0223185.ref062]\]. One possible explanation for this discrepancy may be our strict definition of interventional care.

Poor peripheral muscle strength is associated with a longer duration of MV \[[@pone.0223185.ref053]\]. Previous studies reported positive effects of early exercise in the ICU on these measures \[[@pone.0223185.ref009],[@pone.0223185.ref010],[@pone.0223185.ref013]\]. In this meta-analysis, early mobilization increased the number of ventilator-free days during hospitalization, but not the duration of MV. A possible explanation is that many patients without MV were included \[[@pone.0223185.ref032],[@pone.0223185.ref043],[@pone.0223185.ref048]\]. Highly significant heterogeneity was observed among the 17 studies. As a result, these results should be interpreted with caution.

The mortality rate is a traditional measure of the health status of critically ill patients. Muscle weakness is associated with increased mortality \[[@pone.0223185.ref056]\]. Physical therapy in the ICU had no effect on mortality in many previous systematic reviews and meta-analyses \[[@pone.0223185.ref009], [@pone.0223185.ref010], [@pone.0223185.ref011]\]. Similar to previous studies, early mobilization did not improve ICU mortality, hospital mortality, or 28-day mortality rates in the present study. The discharged-to-home rate is an important prognostic indicator for critically ill patients. In the present study, we first showed that early mobilization increased the discharged-to-home rate compared to the control group.

According to convergent evidence-based data, physical therapy in the ICU is safe \[[@pone.0223185.ref064]\]. In this meta-analysis, early mobilization did not increase the rate of adverse events compared with the control group. This finding is consistent with previous studies \[[@pone.0223185.ref018],[@pone.0223185.ref023],[@pone.0223185.ref011],[@pone.0223185.ref062]\].

Study limitations {#sec025}
=================

Some important limitations of this systematic review and meta-analysis should be noted. First, the definitions, frequency, duration, intensity, volume and treatment time of early mobilization varied across the different studies. As a result, substantial variations in the results were observed. Second, most of the included studies did not adopt sufficient randomization and allocation concealment methods or appropriate blinding methods. Therefore, many sources of bias existed among the included studies. Third, some heterogeneity (e.g., type of outcomes, instruments used, and timing of assessment) existed in the included studies, which limited the possibility of performing additional meta-analyses.

Conclusions {#sec026}
===========

Regardless of the different techniques and periods of mobilization applied, early mobilization may be initiated safely in the ICU setting and appears to decrease the incidence of ICU-AW, improve the functional capacity, and increase the number of patients who are able to stand, number of ventilator-free days and discharged-to-home rate without increasing the rate of adverse events. However, due to the substantial heterogeneity among the included studies, the evidence has a low quality and the results of this study should be interpreted with caution. Further large-scale and well-designed research studies are needed to provide more robust evidence to support the effectiveness and safety of the early mobilization of critically ill patients in the ICU setting.
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